Research

• Grant Applications
• Research News & Reports
  • Teva Pharmaceutical Industries to Purchase Huntexil from Neurosearch
  • Postcard from CHDI February 2011
  • HD Insights Volume 3
  • Auspex Pharmaceuticals Plans Phase III Clinical Trial for Chorea in HD Patients
  • Research News Archive
  • Roche and ISIS form HD Alliance
  • FDA Selects HD for Patient-Focused Drug Development
  • ASO treatment delivered to Alzheimer's patients in Phase I Study
  • Pharmacological Treatment of Chorea in HD Clinical Practice
• Research Webinar Series
• Clinical Trials
• HD Gene Symposium: 20 Years
• Therapies in Pipeline
• Research Conferences
• Scientific Advisory Board
• Research Pipeline
• Stem Cells
• HDBuzz
• HD Glossary
• Links to Other Research
• Past & Future
• HD Insights
• Reports Library

HD Insights is a publication whose mission is to promote, disseminate and facilitate research in Huntington's disease and is targeted at HD researchers around the globe, in academia and industry.

Dr. Ray Dorsey, Associate Professor of Neurology and Director of the Johns Hopkins Parkinsons's Disease and Movement Disorders Center is the editor. Ray is well-known in the HD community as a researcher and clinician who understands the challenges HD presents to families affected by the disease, and has been an advocate for proactive communication of clinical trial information and outcomes to trial participants.

Future issues of HD Insights will be posted on the HDSA website as they are published.

To view the PDF version of HD Insights Volume 3 please click here